New York Eye and Ear Infirmary
Adjust: Text Size Make Font Smaller Make Font Larger Print this Page: Normal Print Friendly Large Print Friendly Accessibility Info

Biomarker/Gene Expression Pilot Study on Ocular Myasthenia Gravis

This study is currently recruiting participants.


To conduct a pilot study to identify potential serum biomarkers (DNA polymorphisms, circulating microRNA, white blood cell mRNA, nanoparticle proteomics)  and link these with clinical phenotypes in a cohort of ocular myasthenia gravis (OMG) patients with precisely defined clinical characteristics.  

Contact Information

Dr. Rudrani Banik, Neuro-Ophthalmologist

Katy Tai, Research Manager at 212-979-4251


Home > Current Research > Clinical Trials in Ophthalmology >Biomarker/Gene Expression Pilot Study on Ocular Myasthenia Gravis